Published in Gene Therapy Weekly, June 7th, 2001
Luigi Naldini, University of Torino Medical School, Italy, and colleagues also reported that they further engineered the vectors and explored several delivery strategies to achieve targeting and exogenous regulation of transgene expression in relevant tissues for gene therapy applications.
"When the improved vectors were administered systemically into the tail veins of severe combined immunodeficiency (SCID) mice, we observed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.